Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination

Abstract Background Tripartite motif 47 (TRIM47) plays a vital role in the carcinogenesis and drug resistance of various cancers, whereas the function of TRIM47 in thyroid carcinoma (TC) remains unclear. Methods Human study and animal experiments were performed. Mass spectrometry, cellular invasion/...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongzhou Liu, Xiaodong Hu, Tan Li, Yuhan Wang, Xiaomin Fu
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1186/s10020-025-01298-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238633761996800
author Hongzhou Liu
Xiaodong Hu
Tan Li
Yuhan Wang
Xiaomin Fu
author_facet Hongzhou Liu
Xiaodong Hu
Tan Li
Yuhan Wang
Xiaomin Fu
author_sort Hongzhou Liu
collection DOAJ
description Abstract Background Tripartite motif 47 (TRIM47) plays a vital role in the carcinogenesis and drug resistance of various cancers, whereas the function of TRIM47 in thyroid carcinoma (TC) remains unclear. Methods Human study and animal experiments were performed. Mass spectrometry, cellular invasion/metastasis assay, chemo-resistance assay, and ubiquitination evaluation were conducted to investigate the interaction between TRIM47 and adenosine deaminases acting on RNA (ADAR). Results TRIM47 expression was increased in human tissues and cell lines of TC. Functional experiments demonstrated that TRIM47 expression enhanced malignant biological behaviors. With mass spectrometry, TRIM47 silencing could significantly decrease the chemo-resistance of TC cells to chemotherapeutic drugs. The interaction between TRIM47 and ADAR was mediated through the ubiquitin–proteasome pathway (UPP), which was approved by RNA interference procedure and co-immunoprecipitation. Conclusion Comprehensively, glycogen synthase kinase-3β (GSK-3β)-associated ubiquitination is critical in the TRIM47-ADAR-GSK-3β axis. This study demonstrates that TRIM47 interacted with ADAR to facilitate ADAR protein degradation via ubiquitination and GSK-3β-associated phosphorylation, which serves as a novel therapeutic avenue for TC. Graphical Abstract
format Article
id doaj-art-8818cdc8f3dd4e18a5ea294010cd6ade
institution Kabale University
issn 1528-3658
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj-art-8818cdc8f3dd4e18a5ea294010cd6ade2025-08-20T04:01:34ZengBMCMolecular Medicine1528-36582025-07-0131111710.1186/s10020-025-01298-zTripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitinationHongzhou Liu0Xiaodong Hu1Tan Li2Yuhan Wang3Xiaomin Fu4Department of Endocrinology, First Hospital of Handan CityDepartment of Endocrinology, The First Medical Center, Chinese PLA General HospitalDepartment of Endocrinology, The First Medical Center, Chinese PLA General HospitalDepartment of Endocrinology, The First Medical Center, Chinese PLA General HospitalClinics of Cadre, Department of Outpatient, The First Medical Center, Chinese PLA General HospitalAbstract Background Tripartite motif 47 (TRIM47) plays a vital role in the carcinogenesis and drug resistance of various cancers, whereas the function of TRIM47 in thyroid carcinoma (TC) remains unclear. Methods Human study and animal experiments were performed. Mass spectrometry, cellular invasion/metastasis assay, chemo-resistance assay, and ubiquitination evaluation were conducted to investigate the interaction between TRIM47 and adenosine deaminases acting on RNA (ADAR). Results TRIM47 expression was increased in human tissues and cell lines of TC. Functional experiments demonstrated that TRIM47 expression enhanced malignant biological behaviors. With mass spectrometry, TRIM47 silencing could significantly decrease the chemo-resistance of TC cells to chemotherapeutic drugs. The interaction between TRIM47 and ADAR was mediated through the ubiquitin–proteasome pathway (UPP), which was approved by RNA interference procedure and co-immunoprecipitation. Conclusion Comprehensively, glycogen synthase kinase-3β (GSK-3β)-associated ubiquitination is critical in the TRIM47-ADAR-GSK-3β axis. This study demonstrates that TRIM47 interacted with ADAR to facilitate ADAR protein degradation via ubiquitination and GSK-3β-associated phosphorylation, which serves as a novel therapeutic avenue for TC. Graphical Abstracthttps://doi.org/10.1186/s10020-025-01298-zThyroid carcinomaTripartite motif 47Adenosine deaminases acting on RNAGlycogen synthase kinase-3βUbiquitinationPhosphorylation
spellingShingle Hongzhou Liu
Xiaodong Hu
Tan Li
Yuhan Wang
Xiaomin Fu
Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination
Molecular Medicine
Thyroid carcinoma
Tripartite motif 47
Adenosine deaminases acting on RNA
Glycogen synthase kinase-3β
Ubiquitination
Phosphorylation
title Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination
title_full Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination
title_fullStr Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination
title_full_unstemmed Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination
title_short Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination
title_sort tripartite motif 47 promotes the development of thyroid carcinoma through adar ubiquitination
topic Thyroid carcinoma
Tripartite motif 47
Adenosine deaminases acting on RNA
Glycogen synthase kinase-3β
Ubiquitination
Phosphorylation
url https://doi.org/10.1186/s10020-025-01298-z
work_keys_str_mv AT hongzhouliu tripartitemotif47promotesthedevelopmentofthyroidcarcinomathroughadarubiquitination
AT xiaodonghu tripartitemotif47promotesthedevelopmentofthyroidcarcinomathroughadarubiquitination
AT tanli tripartitemotif47promotesthedevelopmentofthyroidcarcinomathroughadarubiquitination
AT yuhanwang tripartitemotif47promotesthedevelopmentofthyroidcarcinomathroughadarubiquitination
AT xiaominfu tripartitemotif47promotesthedevelopmentofthyroidcarcinomathroughadarubiquitination